Gene therapies, which treat diseases at the genetic level, are becoming increasingly popular for pharmaceutical manufacturers as the efficacy of directly working with the human genome shows promise for effective health outcomes. But as the U.S. Food and Drug Administration approves them for use in the U.S., these drugs carry a hefty...National News
The Center for Medicare and Medicaid Innovation (CMMI) was accused of harming access to innovative drugs during a House Ways and Means Health Subcommittee meeting last week. GOP lawmakers are taking issue on a proposed CMMI model designed to test strategies to make it easier for Medicare patients to afford and access needed prescriptions...
